Early response to vunakizumab and its baseline predictors in patients with moderate-to-severe plaque psoriasis: a post hoc analysis of a phase-III trial.

Saved in:
Bibliographic Details
Title: Early response to vunakizumab and its baseline predictors in patients with moderate-to-severe plaque psoriasis: a post hoc analysis of a phase-III trial.
Authors: Yu, Yangyiyi1 (AUTHOR), Zeng, Jinrong1 (AUTHOR) zengjinrong1989@csu.edu.cn, Lu, Jianyun1 (AUTHOR) xiaoyun3@csu.edu.cn
Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09546634
DOI:10.1080/09546634.2025.2564810